Use of Parenteral Fish Oil in the Management of IF-Associated Liver Disease

Other ILEs that are approved for use in Europe include SMOFLipid (Fresenius Kabi, Austria GmbH; Graz, Austria), Lipoplus (B Braun; Melsungen, Germany), and Omegaven (Fresenius Kabi AG, Bad Homburg VDH, Germany). These formulations utilize the potential anti-in«ammatory bene—t of omega-3 fatty acids. See Table 21.1 for compositions of different parenteral —sh oil emulsions.